Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma-Reference-Cited by-同舟云学术

Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma

Published:2007-09-20 Issue:12 Volume:21 Page:2519-2526
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Neri P,Tassone P,Shammas M,Yasui H,Schipani E,Batchu R B,Blotta S,Prabhala R,Catley L,Hamasaki M,Hideshima T,Chauhan D,Jacob G S,Picker D,Venuta S,Anderson K C,Munshi N C

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404912.pdf

Reference38 articles.

1. Hideshima T, Chauhan D, Podar K, Schlossman RL, Richardson P, Anderson KC . Novel therapies targeting the myeloma cell and its bone marrow microenvironment. Semin Oncol 2001; 28: 607–612.

2. Hideshima T, Anderson KC . Molecular mechanisms of novel therapeutic approaches for multiple myeloma. Nat Rev Cancer 2002; 2: 927–937.

3. Barlogie B, Tricot G, Anaissie E . Thalidomide in the management of multiple myeloma. Semin Oncol 2001; 28: 577–582.

4. Barlogie B . Thalidomide and CC-5013 in multiple myeloma: the University of Arkansas experience. Semin Hematol 2003; 40 (Suppl 4): 33–38.

5. Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T et al. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 2005; 352: 2487–2498.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tandem construction of biological relevant aliphatic 5-membered N-heterocycles;European Journal of Medicinal Chemistry;2022-05

2. Animal Models of Multiple Myeloma Bone Disease;Frontiers in Genetics;2021-06-07

3. Atiprimod triggered apoptotic cell death via acting on PERK/eIF2α/ATF4/CHOP and STAT3/NF-ΚB axis in MDA-MB-231 and MDA-MB-468 breast cancer cells;Molecular Biology Reports;2021-06

4. Atiprimod induce apoptosis in pituitary adenoma: Endoplasmic reticulum stress and autophagy pathways;Journal of Cellular Biochemistry;2019-07-03

5. Kinase inhibitors as potential agents in the treatment of multiple myeloma;Oncotarget;2016-07-20